The Impact of Infectious Mononucleosis History on the Risk of Developing Lymphoma and Nasopharyngeal Carcinoma: A Retrospective Large-Scale Cohort Study Using National Health Insurance Data in South Korea
Open Access
- 15 October 2024
- journal article
- research article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 56 (4) , 1077-1083
Abstract
Purpose This study aimed to assess the long-term risks associated with a history of infectious mononucleosis (IM), primarily caused by the Epstein-Barr virus (EBV). Specifically analyzing the potential increase in developing nasopharyngeal cancer (NPC) and lymphoma in patients with a history of IM and exploring the prevalence of other EBV-associated conditions.Materials and Methods The Korean National Health Insurance Service (NHIS) database was utilized for a retrospective analysis, covering data from 2002 to 2021. A total of 25,582 IM patients and controls were included, with 1:1 propensity score matching. The study monitored outcomes, including lymphoma, NPC, gastric cancer, multiple sclerosis, and all-cause mortality.Results Patients with a history of IM demonstrated a significantly higher incidence of lymphoma (hazard ratio [HR], 5.320; 95% confidence interval [CI], 3.208 to 8.820; p < 0.001) and NPC (HR, 7.116; 95% CI, 1.617 to 31.314; p=0.009) during the follow-up period compared with the control group. Additionally, the IM group showed an increased rate of all-cause mortality (HR, 2.225; 95% CI, 1.858 to 2.663; p < 0.001).Conclusion This study suggests that individuals with a history of IM have an elevated risk of developing lymphoma and NPC in South Korea, emphasizing the importance of vigilant follow-up and monitoring. The results advocate for heightened awareness and potential national monitoring policies to address the long-term health implications of EBV infection and to implement preventive measures.Keywords
Funding Information
- Korean Society of Otorhinolaryngology-Head and Neck Surgery
- National Research Foundation of Korea (RS-2023-00208625)
- Ministry of Science and ICT
This publication has 22 references indexed in Scilit:
- Epstein–Barr virus and multiple sclerosisNature Reviews Microbiology, 2022
- Nasopharyngeal Carcinoma and Its Association with Epstein-Barr VirusHematology/Oncology Clinics of North America, 2021
- Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approachPathology, 2020
- Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a reviewPathology, 2020
- Epidemiologic features of children with Epstein‐Barr virus associated diseases in Hangzhou, ChinaJournal of Medical Virology, 2019
- Latency and lytic replication in Epstein–Barr virus-associated oncogenesisNature Reviews Microbiology, 2019
- Primary Epstein-Barr virus infectionJournal of Clinical Virology, 2018
- Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccinesPapillomavirus Research, 2016
- The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccineJournal of Infection and Public Health, 2016
- Characteristics of Hodgkin's Lymphoma after Infectious MononucleosisNew England Journal of Medicine, 2003